Wednesday, February 21, 2018
 
 
Company News: Page (1) of 1 - 09/10/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Lilly Builds Upon Body of Clinical Evidence for CYRAMZA® (ramucirumab) with Phase 3 RANGE Data Demonstrating Superior Progression-Free Survival in Advanced or Metastatic Urothelial Cancer
Randomized, placebo-controlled study confirms ramucirumab, in combination with docetaxel, significantly extended progression-free survival (PFS) in patients with platinum-refractory advanced urothelia...
(September 10, 2017)
This article is no longer available,but here are some related topics.


Page: 1


Related Keywords:USA,Medicine,Disease,Surgery,healthcare,medical technologists,Pregnancy,Cancer,Surgery,Medication,Womens Health,Pregnancy,Science,Medical,Biology,Cancer,Other,Women,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • SourceLink Partners with MassMedia Health to Provide Medicare Age-In Data to Healthcare Groups
  • Global Probiotics Industry
  • Global Brain Monitoring Devices Industry
  • Microbubbles/Ultrasound Contrast Agents Market Worth 1,584.5 Million USD by 2024, Says Meticulous Research™
  • Rehabilitation Equipment Market To Witness Enhanced Demand From Hospitals & Clinics, Home Care And Rehabilitation Centers Till 2022 | Million Insights

    Cancer
  • Bolivian Government Invests in State-of-the-art Cancer Care From Elekta
  • 2018 Global Endometriosis Strategic Business Report - Developing Regions Exhibit Immense Growth Potential
  • Cannabics Pharmaceuticals Hires Chief Data Officer to Address Industry Compliance and Utilization/Analytics Application
  • OWC Pharmaceutical Research Corp. Appoints Dr. Oron Yacoby Zeevi as its Chief Scientific Officer
  • Israel Scientific Study: Cannabis Safe and Effective for Regular Use in the Elderly; Can Decrease the Use of Other Prescription Medicines, Including Opioids
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines